- Stroke mechanisms and prevention in intracranial atherosclerosis
-
Ha SH, Kim BJ
- KMID: 2570273
- Cardiovasc Prev Pharmacother.
- 2025 Jul;7(3):94-101.
- doi: 10.36011/cpp.2025.7.e10
Intracranial atherosclerosis (ICAS) is a leading cause of ischemic stroke worldwide, with a particularly high prevalence among Asian populations. While early research primarily attributed this to systemic risk factors such... -
- CITED
-
- Close
- SHARE
-
- Close
- 2024 Cardio-cerebrovascular disease fact sheet in Korea
-
Han K, Jung JH, Choi SS, Ko SH, Korean Society of Cardio-cerebrovascular Disease Prevention
- KMID: 2570272
- Cardiovasc Prev Pharmacother.
- 2025 Jul;7(3):85-93.
- doi: 10.36011/cpp.2025.7.e13
Background: Cardiovascular disease (CVD) is the second most common cause of death in Korea. We investigated the incidence rate of CVD in the Korean adult population using the Korean National... -
- CITED
-
- Close
- SHARE
-
- Close
- Zilebesiran: an RNA therapeutic agent interfering with angiotensinogen synthesis
-
Choi WG
- KMID: 2570274
- Cardiovasc Prev Pharmacother.
- 2025 Jul;7(3):102-108.
- doi: 10.36011/cpp.2025.7.e12
Hypertension remains a leading modifiable risk factor for cardiovascular morbidity and mortality worldwide, yet rates of blood pressure control remain suboptimal despite the availability of multiple classes of antihypertensive agents.... -
- CITED
-
- Close
- SHARE
-
- Close
- The distribution of artificial intelligence–derived retinal cardiovascular risk scores and conventional risk factors in two Korean health screening cohorts: a descriptive study
-
Cho J, Seo J, Park J, Nam D, Park TH, Thakur S, Rim TH, Choi Bh, Jang M
- KMID: 2570271
- Cardiovasc Prev Pharmacother.
- 2025 Jul;7(3):73-84.
- doi: 10.36011/cpp.2025.7.e14
Background: Although retinal imaging–based artificial intelligence (AI) tools have recently been introduced for cardiovascular disease (CVD) risk assessment, little is known about the distribution of these AI-derived scores across the... -
- CITED
-
- Close
- SHARE
-
- Close
- Glucagon-like peptide-1 receptor agonists improve cholesterol metabolism by inhibiting SREBP-2 via SIRT6-AMPK pathway in HepG2 cells treated with palmitic acid
-
Lee J, Rhee EJ, Lim YM, Hong SW, Lee WY
- KMID: 2570270
- Cardiovasc Prev Pharmacother.
- 2025 Jul;7(3):61-72.
- doi: 10.36011/cpp.2025.7.e11
Background: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) exhibit not only hypoglycemic effects but also protective effects against nonalcoholic fatty liver disease and cardiovascular diseases, conditions that are associated with dyslipidemia. Methods: To... -
- CITED
-
- Close
- SHARE
-
- Close
